Liane Teplitsky Biography and Net Worth

Liane Teplitsky joined Pulse Biosciences in April 2026 as Chief Operating Officer. Ms. Teplitsky is a MedTech executive with a strong track record of building and growing healthcare technology businesses, bringing expertise that spans product and therapy development, clinical strategy, and global commercialization with a focus on advancing cardiovascular care. Prior to joining Pulse, Ms. Teplitsky served as CEO of Artedrone, leading strategy and development of an autonomous robotic solution for stroke treatment. Previously, she held senior leadership roles at Abbott and St. Jude Medical, contributing to the development, clinical validation, and global adoption of cardiovascular and electrophysiology therapies. Ms. Teplitsky also served as President of Robotics, Technology and Data Solutions at Zimmer Biomet, leading global efforts in robotics and digital health. She currently serves as Chair of the Board of Carvolix, a French based MedTech company.  Ms. Teplitsky has been recognized as one of Fierce Pharma’s Fiercest Women in Life Sciences and among the 50 Most Powerful Women in Technology and is committed to developing strong teams and future leaders. Ms. Teplitsky earned an M.S. in Biomedical Engineering from Duke University and B.S. degrees in Electrical Engineering and Physiology from the University of Saskatchewan.